Le Carter Q, Gettman Matthew T
Department of Urology, Mayo Clinic, Gonda 7S, 200 First Street, SW, Rochester, MN 55905, USA.
Expert Rev Anticancer Ther. 2006 Jul;6(7):1003-11. doi: 10.1586/14737140.6.7.1003.
Radical retropubic prostatectomy is the current gold standard for surgical removal of the prostate gland. Recently, laparoscopic radical prostatectomy has been developed in an attempt to decrease surgical morbidity, and the technical difficulty of laparoscopy has been countered with the development of the da Vinci robotic interface. Studies that have compared the minimally invasive approaches with the traditional open approach have reported comparable perioperative outcomes. While long-term oncological data are available for open prostatectomy, there are only short-term studies available for laparoscopic prostatectomy. Functional outcomes, including urinary continence and sexual function, appear to be similar between the surgical approaches in the short term. However, currently, costs appear to favor open surgery, with the da Vinci-assisted prostatectomy having the highest expenses. Longer-term data are required to confidently determine the optimal balance between morbidity, oncological efficacy, functional outcomes and cost among the differing surgical approaches.
耻骨后根治性前列腺切除术是目前手术切除前列腺的金标准。最近,腹腔镜根治性前列腺切除术已被开发出来,旨在降低手术发病率,随着达芬奇机器人接口的发展,腹腔镜手术的技术难度也得到了克服。将微创方法与传统开放方法进行比较的研究报告了相似的围手术期结果。虽然开放前列腺切除术有长期的肿瘤学数据,但腹腔镜前列腺切除术只有短期研究。包括尿失禁和性功能在内的功能结果在短期内似乎在手术方法之间相似。然而,目前,成本似乎有利于开放手术,达芬奇辅助前列腺切除术费用最高。需要更长时间的数据来确定不同手术方法在发病率、肿瘤学疗效、功能结果和成本之间的最佳平衡。